Metraipolis › archive › dc_69e59f59eccb

Development and Pharmacokinetic Evaluation of Newly Formulated Letrozole Non-Aqueous Nanoemulgel Transdermal Systems for Hormone-Dependent Breast Cancer Therapy — Europe PMC PMID:41304782

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41304782
DOI
10.3390/pharmaceutics17111444
License (as archived)
solo-consultazione
Archived
2026-11-08T17:24:43.706Z
SHA-256 of the archived text
b1744eb124543701b2cfd0dacd91669fbc54fad8d565afe60b6cd9bf5b38df60
Stable URL of this page
https://metraipolis.com/documento/dc_69e59f59eccb

How to cite

Development and Pharmacokinetic Evaluation of Newly Formulated Letrozole Non-Aqueous Nanoemulgel Transdermal Systems for Hormone-Dependent Breast Cancer Therapy — Europe PMC PMID:41304782 — Europe PMC (en), https://europepmc.org/article/MED/41304782 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69e59f59eccb (Metraipolis archive dc_69e59f59eccb, sha256 b1744eb124543701b2cfd0dacd91669fbc54fad8d565afe60b6cd9bf5b38df60)
BibTeX
@misc{dc69e59f59eccb,
  title = {Development and Pharmacokinetic Evaluation of Newly Formulated Letrozole Non-Aqueous Nanoemulgel Transdermal Systems for Hormone-Dependent Breast Cancer Therapy — Europe PMC PMID:41304782},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41304782},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69e59f59eccb; sha256 b1744eb124543701b2cfd0dacd91669fbc54fad8d565afe60b6cd9bf5b38df60},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304782. Agents can read the archived copy with the MCP tool read_document.